EluRyng FDA Approval History
Last updated by Judith Stewart, BPharm on Jan 14, 2020.
FDA Approved: Yes (First approved December 11, 2019)
Brand name: EluRyng
Generic name: ethinyl estradiol and etonogestrel
Dosage form: Vaginal Ring
Company: Amneal Pharmaceuticals LLC
Treatment for: Birth Control
EluRyng (ethinyl estradiol/etonogestrel vaginal ring) is an estrogen/progestin combination hormonal contraceptive (CHC) indicated for use by women to prevent pregnancy.
EluRyng is the first approved generic version of NuvaRing.
Development timeline for EluRyng
| Date | Article |
|---|---|
| Dec 12, 2019 | Approval FDA Approves EluRyng (etonogestrel/ethinyl estradiol vaginal ring), the First Generic NuvaRing |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
